Biotech · Private company
Allist Pharmaceuticals, Inc.
Track this companyFree. Adds Allist Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- BinimetinibPhase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- JAB-3312Phase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- OsimertinibPhase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- SotorasibPhase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Study to Compare Furmonertinib to Platinum-Based Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations (FURVENT)PHASE3 · ACTIVE_NOT_RECRUITING · started Jun 1, 2023ClinicalTrials.gov NCT05607550 · fetched Nov 12, 2026
- JAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid TumorsPHASE1_PHASE2 · COMPLETED · started Mar 23, 2021ClinicalTrials.gov NCT04720976 · fetched Nov 12, 2026